Another vaccine is being developed by the US veterinary pharmaceutical company Zoetis. It started developing a jab for animals last year after a dog tested positive for the virus in Hong Kong.

Many dog owners have already heard about the FDA warning and seen the articles on the terrible side effects experienced by ...

Indeed, not soon after the approval of Zoetis’ interleukin 31 ... of vaccine development to create vaccines for companion animals, such as dogs and cats—a market that was estimated to be ...

And while there has been “little evidence of pet-to-human transmission ... a call echoed by the World Health Organization. Vaccine maker Zoetis is hoping to get its experimental vaccine ...

Leerink Partners analyst Daniel Clark reiterated a Buy rating on Zoetis (ZTS – Research Report) on January 13 and set a price target of ...

We recently compiled a list of the 10 Best Pet Stocks To Invest ... producers of medicine and vaccinations for pets and ...

According to Zoetis, 40% of dogs have signs of OA ... If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don't need to ...

Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $75.4 billion ...

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief ...